Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 114

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Dopamine Induces IL-6–Dependent IL-17 Production via D1-Like Receptor on CD4 Naive T Cells and D1-Like Receptor Antagonist SCH-23390 Inhibits Cartilage Destruction in a Human Rheumatoid Arthritis/SCID Mouse Chimera Model

Nakano, Kazuhisa, Yamaoka, Kunihiro, Hanami, Kentaro, Saito, Kazuyoshi, Sasaguri, Yasuyuki, Yanagihara, Nobuyuki, Tanaka, Shinya, Katsuki, Ichiro, Matsushita, Sho, Tanaka, Yoshiya · 2011 · The Journal of Immunology

Abstract

A major neurotransmitter dopamine transmits signals via five different seven-transmembrane G protein-coupled receptors termed D1–D5. Several studies have shown that dopamine not only mediates interactions into the nervous system, but can contribute to the modulation of immunity via receptors expressed on immune cells. We have previously shown an autocrine/paracrine release of dopamine by dendritic cells (DCs) during Ag presentation to naive CD4+ T cells and found efficacious results of a D1-like receptor antagonist SCH-23390 in the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis and in the NOD mouse model of type I diabetes, with inhibition of Th17 response. This study aimed to assess the role of dopaminergic signaling in Th17-mediated immune responses and in the pathogenesis of rheumatoid arthritis (RA). In human naive CD4+ T cells, dopamine increased IL-6–dependent IL-17 production via D1-like receptors, in response to anti-CD3 plus anti-CD28 mAb. Furthermore, dopamine was localized with DCs in the synovial tissue of RA patients and significantly increased in RA synovial fluid. In the RA synovial/SCID mouse chimera model, although a selective D2-like receptor antagonist haloperidol significantly induced accumulation of IL-6+ and IL-17+ T cells with exacerbated cartilage destruction, SCH-23390 strongly suppressed these responses. Taken together, these findings indicate that dopamine released by DCs induces IL-6–Th17 axis and causes aggravation of synovial inflammation of RA, which is the first time, to our knowledge, that actual evidence has shown the pathological relevance of dopaminergic signaling with RA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.1002475

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 55

  1. Wickens, 2005, Handbook of Chemical Neuroanatomy., 199
  2. Ganor, 2003, Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration, J. Immunol., 170, 4362, 10.4049/jimmunol.170.8.4362 · DOI · Paper page
  3. Levite, 2001, Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta1 integrin function, Eur. J. Immunol., 31, 3504, 10.1002/1521-4141(200112)31:12<3504::AID-IMMU3504>3.0.CO;2-F · DOI
  4. Franco, 2007, The emergence of neurotransmitters as immune modulators, Trends Immunol., 28, 400, 10.1016/j.it.2007.07.005 · DOI
  5. Pacheco, 2006, Glutamate released by dendritic cells as a novel modulator of T cell activation, J. Immunol., 177, 6695, 10.4049/jimmunol.177.10.6695 · DOI · Paper page
  6. Besser, 2005, Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both, J. Neuroimmunol., 169, 161, 10.1016/j.jneuroim.2005.07.013 · DOI · Paper page
  7. Saha, 2001, Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4+ and CD8+ T cells by D1 dopamine receptors: an in vitro analysis, Int. Immunopharmacol., 1, 1363, 10.1016/S1567-5769(01)00068-6 · DOI
  8. Sarkar, 2006, Cutting edge: stimulation of dopamine D4 receptors induce T cell quiescence by up-regulating Kruppel-like factor-2 expression through inhibition of ERK1/ERK2 phosphorylation, J. Immunol., 177, 7525, 10.4049/jimmunol.177.11.7525 · DOI
  9. Watanabe, 2006, Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3, J. Immunol., 176, 848, 10.4049/jimmunol.176.2.848 · DOI · Paper page
  10. O’Connell, 2006, A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells, Blood, 107, 1010, 10.1182/blood-2005-07-2903 · DOI · Paper page
  11. Kawashima, 2003, The lymphocytic cholinergic system and its contribution to the regulation of immune activity, Life Sci., 74, 675, 10.1016/j.lfs.2003.09.037 · DOI · Paper page
  12. Ghosh, 2003, Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells, Int. Immunopharmacol., 3, 1019, 10.1016/S1567-5769(03)00100-0 · DOI
  13. Bergquist, 1997, Measurements of catecholamine-mediated apoptosis of immunocompetent cells by capillary electrophoresis, Electrophoresis, 18, 1760, 10.1002/elps.1150181009 · DOI
  14. Takahashi, 1992, Human peripheral blood lymphocytes express D5 dopamine receptor gene and transcribe the two pseudogenes, FEBS Lett., 314, 23, 10.1016/0014-5793(92)81452-R · DOI
  15. Ricci, 1999, Dopamine D1-like receptor subtypes in human peripheral blood lymphocytes, J. Neuroimmunol., 96, 234, 10.1016/S0165-5728(99)00042-9 · DOI
  16. McKenna, 2002, Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study, J. Neuroimmunol., 132, 34, 10.1016/S0165-5728(02)00280-1 · DOI · Paper page
  17. Nakano, 2008, Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis, Biochem. Biophys. Res. Commun., 373, 286, 10.1016/j.bbrc.2008.06.012 · DOI
  18. Yang, 2008, IL-21 and TGF-β are required for differentiation of human T(H)17 cells, Nature, 454, 350, 10.1038/nature07021 · DOI · Paper page
  19. Santarlasci, 2009, TGF-β indirectly favors the development of human Th17 cells by inhibiting Th1 cells, Eur. J. Immunol., 39, 207, 10.1002/eji.200838748 · DOI
  20. Kotake, 1999, IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis, J. Clin. Invest., 103, 1345, 10.1172/JCI5703 · DOI · Paper page
  21. Chabaud, 1999, Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium, Arthritis Rheum., 42, 963, 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E · DOI · Paper page
  22. Chabaud, 1998, Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines, J. Immunol., 161, 409, 10.4049/jimmunol.161.1.409 · DOI · Paper page
  23. Chabaud, 2001, Enhancing effect of IL-1, IL-17, and TNF-α on macrophage inflammatory protein-3α production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines, J. Immunol., 167, 6015, 10.4049/jimmunol.167.10.6015 · DOI · Paper page
  24. Katz, 2001, Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1,6, and 8 in skin and synovial fibroblasts: a possible role as a “fine-tuning cytokine” in inflammation processes, Arthritis Rheum., 44, 2176, 10.1002/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4 · DOI
  25. Lundy, 2007, Cells of the synovium in rheumatoid arthritis. T lymphocytes, Arthritis Res. Ther., 9, 202, 10.1186/ar2107 · DOI
  26. Gaffen, 2004, Biology of recently discovered cytokines: interleukin-17—a unique inflammatory cytokine with roles in bone biology and arthritis, Arthritis Res. Ther., 6, 240, 10.1186/ar1444 · DOI
  27. Miranda-Carús, 2006, Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes, Arthritis Rheum., 54, 1151, 10.1002/art.21731 · DOI
  28. Koenders, 2006, Interleukin-17 acts independently of TNF-α under arthritic conditions, J. Immunol., 176, 6262, 10.4049/jimmunol.176.10.6262 · DOI
  29. Koenders, 2005, Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis, Arthritis Rheum., 52, 3239, 10.1002/art.21342 · DOI · Paper page
  30. Genovese, 2010, LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study, Arthritis Rheum., 62, 929, 10.1002/art.27334 · DOI · Paper page
  31. Murphy, 2000, Signaling and transcription in T helper development, Annu. Rev. Immunol., 18, 451, 10.1146/annurev.immunol.18.1.451 · DOI · Paper page
  32. Nakano, 2009, Dopamine released by dendritic cells polarizes Th2 differentiation, Int. Immunol., 21, 645, 10.1093/intimm/dxp033 · DOI
  33. Arnett, 1988, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum., 31, 315, 10.1002/art.1780310302 · DOI · Paper page
  34. Yanagihara, 1996, Phosphorylation of chromogranin A and catecholamine secretion stimulated by elevation of intracellular Ca2+ in cultured bovine adrenal medullary cells, J. Biol. Chem., 271, 17463, 10.1074/jbc.271.29.17463 · doi:10.1074/jbc.271.29.17463
  35. Sasaguri, 2005, Role of histamine produced by bone marrow-derived vascular cells in pathogenesis of atherosclerosis, Circ. Res., 96, 974, 10.1161/01.RES.0000166325.00383.ed · DOI
  36. Nakano, 2007, Rheumatoid synovial endothelial cells produce macrophage colony-stimulating factor leading to osteoclastogenesis in rheumatoid arthritis, Rheumatology (Oxford), 46, 597, 10.1093/rheumatology/kel356 · DOI
  37. Sitaraman, 2001, Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6, J. Clin. Invest., 107, 861, 10.1172/JCI11783 · DOI · Paper page
  38. Geiler, 1994, A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice, Arthritis Rheum., 37, 1664, 10.1002/art.1780371116 · doi:10.1002/art.1780371116
  39. Sarkar, 2010, The immunoregulatory role of dopamine: an update, Brain Behav. Immun., 24, 525, 10.1016/j.bbi.2009.10.015 · DOI · Paper page
  40. Weihe, 1991, Molecular anatomy of the neuro-immune connection, Int. J. Neurosci., 59, 1, 10.3109/00207459108985446 · DOI · Paper page
  41. Bergquist, 1994, Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop, Proc. Natl. Acad. Sci. USA, 91, 12912, 10.1073/pnas.91.26.12912 · DOI · Paper page
  42. Cosentino, 2007, Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop, Blood, 109, 632, 10.1182/blood-2006-01-028423 · DOI · Paper page
  43. Capellino, 2010, Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target, Ann. Rheum. Dis., 69, 1853, 10.1136/ard.2009.119701 · DOI
  44. van Lent, 2003, Expression of the dendritic cell-associated C-type lectin DC-SIGN by inflammatory matrix metalloproteinase-producing macrophages in rheumatoid arthritis synovium and interaction with intercellular adhesion molecule 3-positive T cells, Arthritis Rheum., 48, 360, 10.1002/art.10786 · DOI
  45. Basu, 2000, Dopamine, a neurotransmitter, influences the immune system, J. Neuroimmunol., 102, 113, 10.1016/S0165-5728(99)00176-9 · DOI · Paper page
  46. Saha, 2001, Physiological concentrations of dopamine inhibit the proliferation and cytotoxicity of human CD4+ and CD8+ T cells in vitro: a receptor-mediated mechanism, Neuroimmunomodulation, 9, 23, 10.1159/000049004 · DOI
  47. Kipnis, 2004, Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration, J. Neurosci., 24, 6133, 10.1523/JNEUROSCI.0600-04.2004 · DOI · Paper page
  48. Ramstad, 2000, cAMP-dependent protein kinase (PKA) inhibits T cell activation by phosphorylating ser-43 of raf-1 in the MAPK/ERK pathway, Cell. Signal., 12, 557, 10.1016/S0898-6568(00)00097-8 · DOI
  49. Harada, 1999, Cyclic AMP inhibits the activity of JNK (JNKp46) but not JNKp55 and ERK2 in human helper T lymphocytes, Biochem. Biophys. Res. Commun., 266, 129, 10.1006/bbrc.1999.1783 · DOI
  50. Vang, 2001, Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor, J. Exp. Med., 193, 497, 10.1084/jem.193.4.497 · DOI · Paper page
  51. Hershfield, 2005, New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency, Eur. J. Immunol., 35, 25, 10.1002/eji.200425738 · DOI
  52. Jimenez, 2001, Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation, J. Pharmacol. Exp. Ther., 299, 753, 10.1016/S0022-3565(24)29287-9 · DOI
  53. Aandahl, 2002, Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I, J. Immunol., 169, 802, 10.4049/jimmunol.169.2.802 · DOI
  54. Hashimoto, 2009, Dopamine D1-like receptor antagonist, SCH23390, exhibits a preventive effect on diabetes mellitus that occurs naturally in NOD mice, Biochem. Biophys. Res. Commun., 383, 460, 10.1016/j.bbrc.2009.04.034 · DOI
  55. Okada, 2009, D1-like receptor antagonist inhibits IL-17 expression and attenuates crescent formation in nephrotoxic serum nephritis, Am. J. Nephrol., 30, 274, 10.1159/000225902 · DOI

Cited by

See all 114

Metadata

Authors
Nakano, K., Yamaoka, K., Hanami, K., Saito, K., Sasaguri, Y., Yanagihara, N., Tanaka, S., Katsuki, I., Matsushita, S., & Tanaka, Y.
Venue
The Journal of Immunology
Published
2011-03
Volume
186
Issue
6
Pages
3745-3752
ISSN
  • 0022-1767
  • 1550-6606
Cited by
114
References
12
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dopamine Induces IL-6–Dependent IL-17 Production via D1-Like Receptor on CD4 Naive T Cells and D1-Like Receptor Antagonist SCH-23390 Inhibits Cartilage Destruction in a Human Rheumatoid Arthritis/SCID Mouse Chimera Model. https://app.cochat.ai/papers/10.4049/jimmunol.1002475
The paper
Nakano, K., Yamaoka, K., Hanami, K., Saito, K., Sasaguri, Y., Yanagihara, N., Tanaka, S., Katsuki, I., Matsushita, S., & Tanaka, Y. (2011). Dopamine Induces IL-6–Dependent IL-17 Production via D1-Like Receptor on CD4 Naive T Cells and D1-Like Receptor Antagonist SCH-23390 Inhibits Cartilage Destruction in a Human Rheumatoid Arthritis/SCID Mouse Chimera Model. The Journal of Immunology. https://doi.org/10.4049/jimmunol.1002475

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.